Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

Liothyronine (T3) and Tesamorelin Interaction: Monitor | Peptide Database

Can you take Liothyronine (T3) with Tesamorelin? Monitor interaction (50% confidence). See pharmacological analysis, organ load, safety flags, and dosing guidance.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Compound Profiles

Liothyronine (T3)

Thyroid Hormone | Metabolic Optimization

Liothyronine enters target cells via monocarboxylate transporter 8 (MCT8) and other thyroid hormone transporters, then binds to nuclear thyroid hormone receptors (primarily TR-beta in metabolic tissues and TR-alpha in cardiac tissue). The T3-receptor complex forms heterodimers with retinoid X receptors (RXR) and binds to thyroid hormone response elements (TREs) on DNA, directly modulating gene transcription.

Tesamorelin

GHRH Analog | Visceral Fat Reduction

Subcutaneous injection provides optimal bioavailability for GHRH receptor binding and pulsatile GH release stimulation, selectively targeting visceral adipose tissue while sparing subcutaneous fat..

Combined Organ Load

Frequently Asked Questions

Can I take Liothyronine (T3) with Tesamorelin?

Yes, but with caution. Both Liothyronine (T3) and Tesamorelin promote fat breakdown. While additive fat loss is possible, excessive lipolysis can cause rapid free fatty acid elevation and cardiac strain. Monitor heart rate and adjust doses gradually. Regular monitoring is advised.

Is Liothyronine (T3) and Tesamorelin safe together?

Based on pharmacological analysis, this combination is considered monitor. No critical safety flags identified for this pair.

What are the interactions between Liothyronine (T3) and Tesamorelin?

Both Liothyronine (T3) and Tesamorelin promote fat breakdown. While additive fat loss is possible, excessive lipolysis can cause rapid free fatty acid elevation and cardiac strain. Monitor heart rate and adjust doses gradually. This assessment has 50% confidence and is inferred from pharmacological mechanism analysis.

How should I time Liothyronine (T3) and Tesamorelin?

Liothyronine (T3) has a half-life of ~1 day and Tesamorelin has a half-life of 26-38 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.

Connected topics

Follow this recovery question